Mirae Asset Global Etfs Holdings Ltd. Biocryst Pharmaceuticals Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 127,726 shares of BCRX stock, worth $1.01 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
127,726
Previous 113,527
12.51%
Holding current value
$1.01 Million
Previous $701,000
38.37%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BCRX
# of Institutions
278Shares Held
171MCall Options Held
625KPut Options Held
739K-
Vanguard Group Inc Valley Forge, PA20.3MShares$160 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$158 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.9MShares$93.7 Million1.36% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.09MShares$71.8 Million5.66% of portfolio
-
State Street Corp Boston, MA8.85MShares$69.9 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.47B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...